Polyherbal formulations have long been used in traditional medicine for their potential therapeutic benefits, including renal protection. Recent scientific studies have provided substantial evidence supporting the nephroprotective effects of these formulations. The renal protective effects of ZTN polyherbal formula was studied, evaluations of kidney weight, examination of key biochemical markers in male and female rats and histopathological analysis of both liver and kidney sections were also analyzed. The results of this study are as follows:
ZTN polyherbal formulation increases kidney weight in rat
The administration of ZTN polyherbal formulation exhibited a dose-dependent increase in kidney weight. Fig 1 shows observable differences in the baseline and treatment responses between male and female rats; male rats in the control group had a higher average kidney weight (1.2 grams) compared to female rats (1.1 grams). Both male and female rats showed a similar increase in kidney weight with the 100 mg treated group: the male rats averaging 1.3 grams and female rats averaging 1.2 grams. The 250 mg/kg treated group, male rats had a more pronounced increase (1.5 grams) compared to female rats (1.4 grams). The slight gain of weight observed in the rat kidneys post treatment was not accompanied with renal dysfunction, it can be attributed to physiological hypertrophy because of increased metabolism that the ZTN polyherbal formulation posed (
Saha et al., 2020).
ZTN polyherbal formulation enhanced renal function through modulation of kidney enzymes
The measurement of uric acid secretion as a biochemical marker to evaluate the effects of ZTN polyherbal herbal formulation demonstrate a dose-dependent decrease in uric acid levels in both male and female rats. Fig 2 shows a significant decrease in the level of uric acid secretion at 100 mg/kg treated group and a higher decrease at the of 250 mg/kg treated group when compared with the control group. This suggests a stronger effect of the herbal formulation at this concentration. The hypouricemic effect of the polyherbal extract can be attributed to the potential of each of the ZTN constituents having an antioxidant and anti-inflammatory properties, enhancing renal excretion of uric acid and mitigate oxidative stress. A report from a previous study has indicated the nephroprotective efficacy of polyherbal formulations in diabetic models, where the extracts significantly reduced uric acid levels and improved renal function
(Kausar et al., 2021).
In addition, measurement of BUN level in ZTN polyherbal treated groups and control group was carried out to evaluate renal function after ZTN polyherbal treatments. The polyherbal formulation demonstrate a notable decrease in BUN levels in both male and female rats, with female rats exhibiting higher baseline levels but a greater reduction upon treatment. Fig 2 shows that Female rats in the control group exhibited higher baseline BUN levels (120 mg/dl) compared to male rats (100 mg/dl). Both male and female rat in 100 mg/kg ZTN polyherbal treated group showed a decrease in BUN levels, but the reduction was more pronounced in male rats (20 mg/dl reduction) compared to female rats (30 mg/dl reduction). The higher concentration (250 mg/kg) group demonstrate a significant decrease in BUN levels in both male and female rats. In male rats, BUN level decreased to 50 mg/dl, while a 60 mg/dl reduction was observed in female rats. The significant reduction in BUN levels at higher concentration suggests enhanced renal function or protection against renal damage. Studies have demonstrated that polyherbal formulations can effectively reduce BUN levels, indicating improved renal clearance and reduced protein catabolism.
Furthermore, the examination of creatinine level also revealed the impact of ZTN polyherbal formulation on renal function in both male and female rats. ZTN polyherbal formulation posed a dose-dependent, gender specific and statistically significant decrease in the creatinine levels post treatment. Fig 2 shows the analysis of creatinine levels reveals notable gender differences in response to the polyherbal extract treatments, with statistically significant differences highlighted. Female rats in the control group exhibited higher baseline creatinine levels (1.2 mg/dl) compared to male rats (1.0 mg/dl), with the difference being statistically significant (
p<0.05). Both genders showed a decrease in creatinine levels, but the reduction was more pronounced in female rats (0.3 mg/dl reduction) compared to male rats (0.2 mg/dl reduction), with the differences being statistically significant (p<0.05). The higher dose of 250 mg led to a significant decrease in creatinine levels for both genders. Male rats showed a 0.5 mg/dl reduction, while female rats exhibited a 0.6 mg/dl reduction, with both reductions being statistically significant (p<0.01). These differences may be due to sex-specific metabolic and physiological factors, such as hormonal influences on renal function and oxidative stress response. The observed gender differences underscore the importance of considering sex-specific factors in the pharmacological evaluation of herbal treatments (
Liu et al., 2024). The reduction in creatinine levels indicates improved renal filtration efficiency, likely due to the antioxidant and anti-inflammatory properties of the polyherbal extract. This observation aligns with findings from studies on traditional Ayurvedic formulations, which showed significant improvements in creatinine clearance and renal function
(Gaurav et al., 2023).
Effects of ZTN polyherbal formulation on kidney and liver tissues
The histological comparison between male and female rats shows that both genders respond similarly to the polyherbal extracts at both 100 mg and 250 mg dosages. The control groups for both genders show normal liver and kidney histology, while the treated groups exhibit dose-dependent pathological changes. Fig 3 shows the examination of histological sections liver from both polyherbal treated and untreated groups demonstrate a dose-dependent response in liver tissue integrity and pathology. The control group displays normal liver architecture. while the 100 mg dosage shows mild histological changes and signs of inflammation. The 250 mg/kg treated group demonstrates a higher level of histological changes including significant inflammation, hepatocyte necrosis and disrupted liver architecture.
Similarly, the histological examination of sections of kidney tissues from the ZTN polyherbal formulation treated groups demonstrates a dose-dependent response. Fig 4 shows that the control group display normal kidney tissue environment while the 100 mg/kg treated groups demonstrate mild pathological changes such as slight epithelial vacuolation and mild inflammatory infiltration. The 250 mg/kg treated groups exhibit more pronounced changes, including significant glomerular hypertrophy, tubular necrosis, increased inflammatory infiltration, and vascular congestion. These findings suggest that higher doses of polyherbal extracts may induce significant kidney stress or damage, emphasizing the need for careful dosage regulation in therapeutic applications. Similar results have been reported in studies where polyherbal extracts such as those containing
Boerhavia diffusa exhibited significant nephroprotective effects by modulating renal hypertrophy and improving renal function
(Chaudhuri et al., 2023).